• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受药代动力学建议是否会影响住院治疗?一项成本效益分析。

Does accepting pharmacokinetic recommendations impact hospitalization? A cost-benefit analysis.

作者信息

Destache C J, Meyer S K, Rowley K M

机构信息

Clinical Pharmacokinetic Service, AMI Saint Joseph Hospital, Omaha, Nebraska.

出版信息

Ther Drug Monit. 1990 Sep;12(5):427-33. doi: 10.1097/00007691-199009000-00004.

DOI:10.1097/00007691-199009000-00004
PMID:2127325
Abstract

In a prospective, randomized study, 110 adults receiving aminoglycosides were randomized to follow-up by a clinical pharmacokinetic service (CPS). Of the 110 patients, 35 accepted pharmacokinetic recommendations less than 100% of the time. The two groups were similar in age, sex, height, APACHE II score, and initial creatinine clearance. A cost-to-charge ratio was used to derive direct costs of hospitalization and calculate cost-benefit. Patients whose physicians accepted pharmacokinetic recommendations 100% of the time had shorter hospitalizations (322.67 +/- 270.28 h; CPS less than 100%, 699.54 +/- 806.35; p = 0.001) and febrile periods (50.05 +/- 79.38 h; CPS less than 100%, 120.00 +/- 153.23; p = 0.002). Acceptance of CPS recommendations led to adequate peak levels. Acceptance of CPS recommendations led to lower direct costs ($7,102.56 +/- 9,898.19; CPS less than 100%, $19,629.94 +/- 28,051.89; p less than 0.001). Calculated direct cost of the service was $85/patient.

摘要

在一项前瞻性随机研究中,110名接受氨基糖苷类药物治疗的成年人被随机分配接受临床药代动力学服务(CPS)的随访。在这110名患者中,35名患者接受药代动力学建议的时间不到100%。两组在年龄、性别、身高、急性生理学与慢性健康状况评分系统(APACHE II)得分以及初始肌酐清除率方面相似。采用成本收费比来得出住院的直接成本并计算成本效益。医生100%接受药代动力学建议的患者住院时间较短(322.67±270.28小时;CPS低于100%组为699.54±806.35小时;p = 0.001),发热期也较短(50.05±79.38小时;CPS低于100%组为120.00±153.23小时;p = 0.002)。接受CPS建议可使峰值水平达到合适状态。接受CPS建议可降低直接成本(7102.56±9898.19美元;CPS低于100%组为19629.94±28051.89美元;p<0.001)。该服务的计算直接成本为每位患者85美元。

相似文献

1
Does accepting pharmacokinetic recommendations impact hospitalization? A cost-benefit analysis.接受药代动力学建议是否会影响住院治疗?一项成本效益分析。
Ther Drug Monit. 1990 Sep;12(5):427-33. doi: 10.1097/00007691-199009000-00004.
2
Impact of a clinical pharmacokinetic service on patients treated with aminoglycosides: a cost-benefit analysis.临床药代动力学服务对接受氨基糖苷类药物治疗患者的影响:成本效益分析。
Ther Drug Monit. 1990 Sep;12(5):419-26. doi: 10.1097/00007691-199009000-00003.
3
Impact of a clinical pharmacokinetic service on patients treated with aminoglycosides for gram-negative infections.临床药代动力学服务对接受氨基糖苷类药物治疗革兰氏阴性菌感染患者的影响。
DICP. 1989 Jan;23(1):33-8. doi: 10.1177/106002808902300106.
4
A utilization and cost-benefit analysis of an aminoglycoside kinetics monitoring service.一项氨基糖苷类药物动力学监测服务的使用情况及成本效益分析
Clin Invest Med. 1992 Feb;15(1):8-17.
5
Economic impact of remote patient monitoring: an integrated economic model derived from a meta-analysis of randomized controlled trials in heart failure.远程患者监测的经济影响:一项基于心力衰竭随机对照试验荟萃分析的综合经济模型。
Eur J Heart Fail. 2011 Apr;13(4):450-9. doi: 10.1093/eurjhf/hfq232. Epub 2010 Dec 29.
6
Assessment of potential factors associating with costs of hospitalizing cardiovascular diseases in 141 hospitals in Guangxi, China.中国广西141家医院心血管疾病住院费用相关潜在因素评估。
PLoS One. 2017 Mar 16;12(3):e0173451. doi: 10.1371/journal.pone.0173451. eCollection 2017.
7
Aminoglycoside monitoring: use of a pharmacokinetic service versus physician recommendations.
Hosp Formul. 1987 Jan;22(1):92-9, 102.
8
Cost-effectiveness analysis on the use of fidaxomicin and vancomycin to treat Clostridium difficile infection in France.在法国使用非达霉素和万古霉素治疗艰难梭菌感染的成本效益分析。
J Med Econ. 2017 Jul;20(7):678-686. doi: 10.1080/13696998.2017.1302946. Epub 2017 Mar 16.
9
Anticoagulation monitoring by an anticoagulation service is more cost-effective than routine physician care.抗凝监测服务比常规医生护理更具成本效益。
J Vasc Surg. 2011 Nov;54(5):1404-7. doi: 10.1016/j.jvs.2011.05.021. Epub 2011 Jul 13.
10
Identification of children for whom routine monitoring of aminoglycoside serum concentrations is not cost effective.确定常规监测氨基糖苷类血清浓度不具有成本效益的儿童。
J Pediatr. 1986 Nov;109(5):897-901. doi: 10.1016/s0022-3476(86)80722-3.

引用本文的文献

1
Optimizing antimicrobial use: challenges, advances and opportunities.优化抗菌药物使用:挑战、进展与机遇。
Nat Rev Microbiol. 2021 Dec;19(12):747-758. doi: 10.1038/s41579-021-00578-9. Epub 2021 Jun 22.
2
Precision Dosing Priority Criteria: Drug, Disease, and Patient Population Variables.精准给药优先标准:药物、疾病及患者群体变量
Front Pharmacol. 2020 Apr 22;11:420. doi: 10.3389/fphar.2020.00420. eCollection 2020.
3
Therapeutic drug monitoring of gentamicin in patients with bronchopneumonia: cost considerations and patient outcomes.
支气管肺炎患者庆大霉素的治疗药物监测:成本考量与患者预后
Eurasian J Med. 2012 Apr;44(1):1-5. doi: 10.5152/eajm.2012.01.
4
Outcomes in patients with gram-negative sepsis treated with gentamicin.革兰氏阴性菌败血症患者接受庆大霉素治疗的结果。
Ther Adv Drug Saf. 2012 Jun;3(3):109-13. doi: 10.1177/2042098612439495.
5
Aminoglycosides in septic shock: an overview, with specific consideration given to their nephrotoxic risk.氨基糖苷类药物在感染性休克中的应用:综述,特别考虑其肾毒性风险。
Drug Saf. 2013 Apr;36(4):217-30. doi: 10.1007/s40264-013-0031-0.
6
Pharmacogenetics: the therapeutic drug monitoring of the future?药物遗传学:未来的治疗药物监测?
Clin Pharmacokinet. 2001;40(11):783-802. doi: 10.2165/00003088-200140110-00001.
7
Therapeutic drug monitoring: do the improved outcomes justify the costs?治疗药物监测:改善的结果是否证明成本合理?
Clin Pharmacokinet. 2001;40(6):405-9. doi: 10.2165/00003088-200140060-00002.
8
Economic impact of aminoglycoside toxicity and its prevention through therapeutic drug monitoring.氨基糖苷类药物毒性的经济影响及其通过治疗药物监测进行的预防。
Pharmacoeconomics. 1998 Oct;14(4):385-94. doi: 10.2165/00019053-199814040-00005.
9
Computer support for determining drug dose: systematic review and meta-analysis.计算机辅助确定药物剂量:系统评价与荟萃分析。
BMJ. 1999 Apr 10;318(7189):984-90. doi: 10.1136/bmj.318.7189.984.
10
Economic aspects of pharmacokinetic services.药代动力学服务的经济方面。
Pharmacoeconomics. 1993 Jun;3(6):433-6. doi: 10.2165/00019053-199303060-00002.